Incorporation of future costs in health economic analysis publications: current situation and recommendations for the future.
Future costs are not usually included in economic evaluations. The aim of this study was to assess the extent of published economic analyses that incorporate future costs. A systematic review was conducted of economic analyses published from 2008 to 2013 in three general health economics journals: PharmacoEconomics, Value in Health and the European Journal of Health Economics. A total of 192 articles met the inclusion criteria, 94 of them (49.0%) incorporated future related medical costs, 9 (4.2%) also included future unrelated medical costs and none of them included future nonmedical costs. The percentage of articles including future costs increased from 2008 (30.8%) to 2013 (70.8%), and no differences were detected between the three journals. All relevant costs for the perspective considered should be included in economic evaluations, including related or unrelated, direct or indirect future costs. It is also advisable that pharmacoEconomic guidelines are adapted in this sense.
Market Access Department, Janssen-Cilag, Madrid, Spain.
Blanca
B
Gros
Javier
J
Soto Álvarez
Miguel
M
Ángel Casado
D003365:Costs and Cost Analysis / Q000379:methods; D003695:Delivery of Health Care / Q000191:economics; D017850:Economics, Pharmaceutical / Q000639:trends*; D017048:Health Care Costs / Q000639:trends*; D006801:Humans; D010506:Periodicals as Topic / Q000706:statistics & numerical data*
economic analysis; future costs; health economic analysis; publications